These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19049754)

  • 1. The rush to atrial septal defect closure: is the introduction of percutaneous closure driving utilization?
    Karamlou T; Diggs BS; Ungerleider RM; McCrindle BW; Welke KF
    Ann Thorac Surg; 2008 Nov; 86(5):1584-90; discussion 1590-1. PubMed ID: 19049754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
    Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
    Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geography or pathology? Regional variation in atrial septal defect closure rates and techniques.
    Walker WL; Karamlou T; Diggs BS; Ehieli EI; Caddell KA; de la Cruz JS; Welke KF
    Cardiol Young; 2011 Oct; 21(5):577-84. PubMed ID: 21729512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.
    Singh V; Badheka AO; Patel NJ; Chothani A; Mehta K; Arora S; Patel N; Deshmukh A; Shah N; Savani GT; Rathod A; Manvar S; Thakkar B; Panchal V; Patel J; Palacios IF; Rihal CS; Cohen MG; O'Neill W; De Marchena E
    Catheter Cardiovasc Interv; 2015 May; 85(6):1073-81. PubMed ID: 25534392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects.
    Jones TK; Latson LA; Zahn E; Fleishman CE; Jacobson J; Vincent R; Kanter K;
    J Am Coll Cardiol; 2007 Jun; 49(22):2215-21. PubMed ID: 17543643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous closure of atrial septal defects: a decade of experience at a reference center.
    Fiarresga A; De Sousa L; Martins JD; Ramos R; Paramés F; Freitas I; Oliveira JA; Trigo C; Agapito A; Ferreira RC; Pinto F
    Rev Port Cardiol; 2010 May; 29(5):767-80. PubMed ID: 20866006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical versus percutaneous occlusion of ostium secundum atrial septal defects: results and cost-effective considerations in a low-income country.
    Vida VL; Barnoya J; O'Connell M; Leon-Wyss J; Larrazabal LA; Castañeda AR
    J Am Coll Cardiol; 2006 Jan; 47(2):326-31. PubMed ID: 16412855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications.
    Butera G; Carminati M; Chessa M; Youssef R; Drago M; Giamberti A; Pomè G; Bossone E; Frigiola A
    Am Heart J; 2006 Jan; 151(1):228-34. PubMed ID: 16368323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hospital volume on outcomes of percutaneous ASD/PFO closure in pediatric patients.
    Bhatt P; Patel A; Kumar V; Lekshminarayanan A; Patel V; Alapati S; Billimoria ZC
    World J Pediatr; 2018 Aug; 14(4):364-372. PubMed ID: 29508364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for prolonged intensive care treatment following atrial septal defect closure in adults.
    Hörer J; Eicken A; Müller S; Schreiber C; Cleuziou J; Prodan Z; Holper K; Lange R
    Int J Cardiol; 2008 Mar; 125(1):57-61. PubMed ID: 17462760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
    Spies C; Khandelwal A; Timmermanns I; Schräder R
    Am J Cardiol; 2008 Oct; 102(7):902-6. PubMed ID: 18805119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous patent foramen ovale/atrial septal defect closure: just because we can?
    Opotowsky AR; Webb GD
    Ann Thorac Surg; 2009 Oct; 88(4):1386; author reply 1386-7. PubMed ID: 19766861
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience on the way to totally endoscopic atrial septal defect repair.
    Bonaros N; Schachner T; Oehlinger A; Jonetzko P; Mueller S; Moes N; Kolbitsch C; Mair P; Putz G; Laufer G; Bonatti J
    Heart Surg Forum; 2004; 7(5):E440-5. PubMed ID: 15799920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous treatment of patent foramen ovale and atrial septal defects.
    Tobis J; Shenoda M
    J Am Coll Cardiol; 2012 Oct; 60(18):1722-32. PubMed ID: 23040567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort.
    Engelfriet P; Meijboom F; Boersma E; Tijssen J; Mulder B
    Int J Cardiol; 2008 Jun; 126(3):379-85. PubMed ID: 17586067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
    Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of percutaneous atrial septal defect closure on the occurrence of migraine.
    Mortelmans K; Post M; Thijs V; Herroelen L; Budts W
    Eur Heart J; 2005 Aug; 26(15):1533-7. PubMed ID: 15746154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.